[Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 filed for DENTSPLY SIRONA Inc. (XRAY) discloses that director Brian T. Gladden received 222.26 additional restricted stock units (RSUs) on 07/11/2025. The RSUs represent dividend equivalents credited on previously granted awards and carry the same vesting schedule as the underlying grants. Each RSU will convert to one share of common stock when vested. Following this automatic accrual, the director's total beneficial ownership increased to 28,440.469 shares, all held directly. No open-market purchases, sales, or derivative transactions were reported, and no cash consideration was involved (price recorded as $0). An attorney-in-fact signed the filing on 07/15/2025 under a standing power of attorney.

Insights

Securities Analyst

TL;DR: Routine RSU dividend credit; negligible ownership change; neutral signal.

The filing shows a mechanical accrual of 222.26 RSUs credited as dividend equivalents to an existing equity award, increasing Mr. Gladden’s holdings by less than 1%. Because the transaction is non-discretionary, involves no cash outlay, and does not alter the director’s economic exposure materially, it is unlikely to influence investor sentiment. Such credits typically occur quarterly and do not provide insight into insider conviction or forthcoming corporate developments. Accordingly, I view the disclosure as informational but not market-moving.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Gladden Brian T

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/11/2025		A		222.26(1)	A	$0	28,440.469	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jessica Causey, Attorney-in-Fact for Brian T. Gladden	07/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DENTSPLY SIRONA (XRAY) disclose in the latest Form 4?

Director Brian T. Gladden received 222.26 RSUs as dividend equivalents, increasing his direct ownership to 28,440.469 shares.

Was there any cash transaction involved in the insider activity?

No. The RSUs were credited at a price of $0; they represent automatic dividend reinvestment, not a cash purchase.

Does the 222.26 RSU credit indicate insider buying confidence?

It is a routine, non-discretionary accrual tied to previously granted awards, so it does not signal active buying sentiment.

How many XRAY shares does Brian T. Gladden now own?

After the reported transaction, he beneficially owns 28,440.469 shares of DENTSPLY SIRONA common stock.

When was the Form 4 for XRAY filed and signed?

The filing was signed on 07/15/2025 by attorney-in-fact Jessica Causey and covers a transaction dated 07/11/2025.